IssuerAnnouncementDetailsV2Portlet

Actions

Jamjoom Pharmaceuticals Factory Co. Announces the Board of Director's decision regarding the appointment of the Chairman and Vice-Chairman of the Board of Directors, formation of the Board committees, appointment of the Secretary of the Board and appointment of the Company’s representatives to the Capital Market Authority and the Saudi Exchange

4015
JAMJOOM PHARMA
-0.06 %
1447/01/06     01/07/2025 15:37:27

Element ListExplanation
Announcement Detail With reference to the Extraordinary General Assembly meeting held on Wednesday 25/06/2025G, corresponding to 29/12/1446H, in which the members of the Board of Directors of Jamjoom Pharmaceutical Factory Company (the “Company”) were elected for its new term, which will begin on 25/06/2025G, for a period of three years ending on 24/06/2028G.

The Company’s Board of Directors is pleased to announce its decision on 30/06/2025G, corresponding to 05/01/1447H, to appoint the Chairman and Vice-Chairman of the Board of Directors, formation of the Board committees, appointment of the Secretary of the Board and appointment of the Company’s representatives to the Capital Market Authority and Saudi Exchange

First: Appointment of Mr. Mahmoud Yousuf Jamjoom as Chairman of the Company’s Board of Directors.

Second: Appointment of Mr. Ahmed Yousuf Jamjoom as Vice Chairman of the Company’s Board of Directors.

Third: Formation of the “Nomination and Remuneration Committee” consisting of the following members:

Ms. Rania Al Turki (Chairperson)

Ms. Alaa Jamjoom

Mr. Javed Ghulam Mohammed

Mr. Thamer Al-Harthi

Fourth: Formation of the “Audit Committee” consisting of the following members:

Mr. Faris AlGhannam (Chairman)

Mr. Turki Alluhaid

Mr. Marwan Almubarak

Fifth: formation of the “Executive Committee” consisting of the following members:

Mr. Benjamin Togood (Chairman)

Mr. Ahmed Jamjoom

Mr. Javed Ghulam Mohammed

Mr. Tarek Hosni

Mr. Mohammed Mahmoud Jamjoom

Sixth: Appointment of Mr. Faisal Ahmed Linjawy as the Secretary of the Board

Seventh: Appointment of the following representatives of the Company to the Capital Market Authority (CMA) and the Saudi Exchange (Tadawul):

Mr. Ahmed Jamjoom (Vice Chairman)

Mr. Tarek Hosni (Chief Executive Officer)

The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Performance

Add To Watchlist
In your Watchlist
Add To Watchlist
Key Parameters
Last Price
Net Change  (%)
Value Traded (Sar)
Volume Traded
See The Company Profile

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions
NO PORTLET SESSION YET